Loading insider details...
Latest Form 4 (Nov 20, 2024): Sale of 12,099 SYRS shares, $2.4K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 20, 2024 | Syros Pharmaceuticals, Inc. (SYRS) | Sale | 12,099 | $2.4K |
| Nov 4, 2024 | Syros Pharmaceuticals, Inc. (SYRS) | Exercise/Conversion | 18,875 | n/a |
| Apr 5, 2024 | Syros Pharmaceuticals, Inc. (SYRS) | Sale | 10,451 | $51.7K |
| Apr 2, 2024 | Syros Pharmaceuticals, Inc. (SYRS) | Exercise/Conversion | 2,000 | n/a |
| Dec 14, 2023 | Syros Pharmaceuticals, Inc. (SYRS) | Sale | 6,287 | $31.1K |
| Dec 8, 2023 | Syros Pharmaceuticals, Inc. (SYRS) | Sale | 6,287 | $24.8K |
| Nov 2, 2023 | Syros Pharmaceuticals, Inc. (SYRS) | Exercise/Conversion | 18,875 | n/a |
| Aug 2, 2023 | Syros Pharmaceuticals, Inc. (SYRS) | Sale | 7,348 | $29.0K |
| Apr 4, 2023 | Syros Pharmaceuticals, Inc. (SYRS) | Exercise/Conversion | 2,000 | n/a |
| Feb 21, 2023 | Syros Pharmaceuticals, Inc. (SYRS) | Grant/Award | 40,000 | n/a |